503 related articles for article (PubMed ID: 7682708)
21. Control of programmed cell death in normal and leukemic cells: new implications for therapy.
Sachs L; Lotem J
Blood; 1993 Jul; 82(1):15-21. PubMed ID: 8324219
[TBL] [Abstract][Full Text] [Related]
22. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
Shiosaka T; Tanaka Y
Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822
[TBL] [Abstract][Full Text] [Related]
23. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
24. Bax mutations in cell lines derived from hematological malignancies.
Meijerink JP; Smetsers TF; Slöetjes AW; Linders EH; Mensink EJ
Leukemia; 1995 Nov; 9(11):1828-32. PubMed ID: 7475270
[TBL] [Abstract][Full Text] [Related]
25. MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation.
Yang T; Buchan HL; Townsend KJ; Craig RW
J Cell Physiol; 1996 Mar; 166(3):523-36. PubMed ID: 8600156
[TBL] [Abstract][Full Text] [Related]
26. Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.
Klanova M; Andera L; Brazina J; Svadlenka J; Benesova S; Soukup J; Prukova D; Vejmelkova D; Jaksa R; Helman K; Vockova P; Lateckova L; Molinsky J; Maswabi BC; Alam M; Kodet R; Pytlik R; Trneny M; Klener P
Clin Cancer Res; 2016 Mar; 22(5):1138-49. PubMed ID: 26467384
[TBL] [Abstract][Full Text] [Related]
27. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
Katoh O; Takahashi T; Oguri T; Kuramoto K; Mihara K; Kobayashi M; Hirata S; Watanabe H
Cancer Res; 1998 Dec; 58(23):5565-9. PubMed ID: 9850095
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel tyrosine kinase receptor-like molecule in neuroblastomas.
Maminta ML; Williams KL; Nakagawara A; Enger KT; Guo C; Brodeur GM; Deuel TF
Biochem Biophys Res Commun; 1992 Dec; 189(2):1077-83. PubMed ID: 1281989
[TBL] [Abstract][Full Text] [Related]
30. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Taipale J; Matikainen S; Hurme M; Keski-Oja J
Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
[TBL] [Abstract][Full Text] [Related]
31. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
Fang F; Ahmad S; Lei J; Klecker RW; Trepel JB; Smithgall TE; Glazer RI
Biochemistry; 1993 Jul; 32(27):6995-7001. PubMed ID: 8334128
[TBL] [Abstract][Full Text] [Related]
32. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells.
Naumovski L; Cleary ML
Blood; 1994 Apr; 83(8):2261-7. PubMed ID: 8161792
[TBL] [Abstract][Full Text] [Related]
33. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation.
Matsui M; Tokuhara M; Konuma Y; Nomura N; Ishizaki R
Oncogene; 1990 Mar; 5(3):249-55. PubMed ID: 2107490
[TBL] [Abstract][Full Text] [Related]
34. An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.
Vrana JA; Bieszczad CK; Cleaveland ES; Ma Y; Park JP; Mohandas TK; Craig RW
Cancer Res; 2002 Feb; 62(3):892-900. PubMed ID: 11830549
[TBL] [Abstract][Full Text] [Related]
35. p16INK4A sensitizes human leukemia cells to FAS- and glucocorticoid-induced apoptosis via induction of BBC3/Puma and repression of MCL1 and BCL2.
Obexer P; Hagenbuchner J; Rupp M; Salvador C; Holzner M; Deutsch M; Porto V; Kofler R; Unterkircher T; Ausserlechner MJ
J Biol Chem; 2009 Nov; 284(45):30933-40. PubMed ID: 19737931
[TBL] [Abstract][Full Text] [Related]
36. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.
Reed JC; Cuddy M; Haldar S; Croce C; Nowell P; Makover D; Bradley K
Proc Natl Acad Sci U S A; 1990 May; 87(10):3660-4. PubMed ID: 1692620
[TBL] [Abstract][Full Text] [Related]
37. Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone.
Zhang D; Li F; Weidner D; Mnjoyan ZH; Fujise K
J Biol Chem; 2002 Oct; 277(40):37430-8. PubMed ID: 12149273
[TBL] [Abstract][Full Text] [Related]
38. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen.
Fujise K; Zhang D; Liu J; Yeh ET
J Biol Chem; 2000 Dec; 275(50):39458-65. PubMed ID: 10978339
[TBL] [Abstract][Full Text] [Related]
39. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines.
Cioca DP; Aoki Y; Kiyosawa K
Cancer Gene Ther; 2003 Feb; 10(2):125-33. PubMed ID: 12536201
[TBL] [Abstract][Full Text] [Related]
40. Regulation of c-fos and c-jun protooncogene expression by the Ca(2+)-ATPase inhibitor thapsigargin.
Schönthal A; Sugarman J; Brown JH; Hanley MR; Feramisco JR
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7096-100. PubMed ID: 1714585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
